300
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Medicinal plant compounds as promising inhibitors of coronavirus (COVID-19) main protease: an in silico study

, , , ORCID Icon, ORCID Icon &
Pages 8073-8084 | Received 07 Sep 2020, Accepted 15 Mar 2021, Published online: 10 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianhong Zhang, Xinhui Wu, Baiyin Zhong, Qicheng Liao, Xin Wang, Yuankang Xie & Xiao He. (2023) Review on the Diverse Biological Effects of Glabridin. Drug Design, Development and Therapy 17, pages 15-37.
Read now
Gisele Rocha Aguiar, Telma Leda Gomes de Lemos, Raimundo Braz-Filho, Aluísio Marques da Fonseca, Emmanuel Silva Marinho, Paulo Riceli Vasconcelos Ribeiro, Kirley Marques Canuto & Francisco José Queiroz Monte. (2023) Synthesis and in silico study of chenodeoxycholic acid and its analogues as an alternative inhibitor of spike glycoprotein of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 41:17, pages 8334-8348.
Read now

Articles from other publishers (2)

Maicon S. N. dos Santos, Jo鉶 H. C. Wancura, Carolina E. D. Oro, Rog閞io M. Dallago & Marcus V. Tres. (2022) Opportunities and Challenges of Plant Bioactive Compounds for Food and Agricultural-Related Areas. Phyton 91:6, pages 1105-1127.
Crossref
Priyanka Saha, Subhankar Bose, Amit Kumar Srivastava, Anis Ahmad Chaudhary, Rajiv Lall & Sahdeo Prasad. (2021) Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules 26:22, pages 6783.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.